Literature DB >> 30296796

Facial Scar Improvement Procedures.

Christopher Ian Newberry1, J Regan Thomas2, Eric W Cerrati1.   

Abstract

Scars are a natural part of dermal healing following lacerations, incisions, or tissue loss. The ideal scar is narrow, flat, level with surrounding tissue, and difficult for the untrained eye to see due to color match and placement parallel to relaxed skin tension lines; however, scarring that is dyspigmented, hypertrophied, widened, contracted, or atrophic can be aesthetically displeasing or causing functional limitations. When the scar has unfavorable characteristics, scar revision is often indicated and the cosmetic surgeon must be knowledgeable of the minimally invasive as well as surgical techniques to improve aesthetics, reduced reoccurrence, or correct functional limitations. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30296796     DOI: 10.1055/s-0038-1669400

Source DB:  PubMed          Journal:  Facial Plast Surg        ISSN: 0736-6825            Impact factor:   1.446


  4 in total

1.  Nanofat Injection for the Treatment of Depressed Facial Scars.

Authors:  Rong Huang; Hu Jiao; Jincai Fan; Liqiang Liu; Jia Tian; Cheng Gan; Zengjie Yang; Tiran Zhang; Yan Zeng; Zhiguo Su
Journal:  Aesthetic Plast Surg       Date:  2021-02-26       Impact factor: 2.326

Review 2.  Scar Revisions.

Authors:  Anna Skochdopole; Rami P Dibbs; Shayan M Sarrami; Robert F Dempsey
Journal:  Semin Plast Surg       Date:  2021-06-08       Impact factor: 2.314

Review 3.  Revisional Techniques for Secondary Cleft Lip Deformities.

Authors:  Shayan M Sarrami; Anna J Skochdopole; Andrew M Ferry; Edward P Buchanan; Larry H Hollier; Robert F Dempsey
Journal:  Semin Plast Surg       Date:  2021-06-08       Impact factor: 2.314

4.  Exosome loaded genipin crosslinked hydrogel facilitates full thickness cutaneous wound healing in rat animal model.

Authors:  Qijun Li; Shiqiang Gong; Weifan Yao; Ziting Yang; Renjun Wang; Zhaojin Yu; Minjie Wei
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.